Vitrolife AB
Nasdaq Stockholm · LEI 5493001WDZMONMSPPR49· Fiscal year 2025
Staff cost per employee
Not disclosed
Employees
Not disclosed
Quick read
- Revenue fell 4.7% year over year.
- Operating loss of $474.8M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Google Finance ↗
Investor metrics
2025
- Operating margin
- -140.6%
- Net margin
- -145.7%
- ROE
- -63.5%
- Debt-to-equity
- 40.9%
- Equity ratio
- 71.0%